SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Alpha Cognition Announces Real-World Evidence on ZUNVEYL Use

Alpha Cognition Inc. announced initial results from CONVERGE, an ongoing retrospective real-world evidence evaluation using longitudinal long-term care medication-administration data for ZUNVEYL®(Benzgalantamine).

ACOGCNVRG